Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Correction to: Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC).

Foeldvari I, Klotsche J, Simonini G, Edelsten C, Angeles-Han ST, Bangsgaard R, de Boer J, Brumm G, Torrent RB, Constantin T, DeLibero C, Diaz J, Gerloni VM, Guedes M, Heiligenhaus A, Kotaniemi K, Leinonen S, Minden K, Miranda V, Miserocchi E, Nielsen S, Niewerth M, Pontikaki I, de Vicuna CG, Zilhao C, Yeh S, Anton J.

Pediatr Rheumatol Online J. 2020 Feb 11;18(1):14. doi: 10.1186/s12969-019-0396-4.

2.

Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC).

Foeldvari I, Klotsche J, Simonini G, Edelsten C, Angeles-Han ST, Bangsgaard R, de Boer J, Brumm G, Torrent RB, Constantin T, DeLibero C, Diaz J, Gerloni VM, Guedes M, Heiligenhaus A, Kotaniemi K, Leinonen S, Minden K, Miranda V, Miserocchi E, Nielsen S, Niewerth M, Pontikaki I, de Vicuna CG, Zilhao C, Yeh S, Anton J.

Pediatr Rheumatol Online J. 2019 Oct 1;17(1):66. doi: 10.1186/s12969-019-0345-2. Erratum in: Pediatr Rheumatol Online J. 2020 Feb 11;18(1):14.

3.

Management of paediatric ocular inflammatory disease in the UK: national survey of practice.

Solebo AL, Rahi JS, Edelsten C, Ashworth JL, Dick AD; Paediatric Ocular Inflammation Group.

Eye (Lond). 2019 Jul 9. doi: 10.1038/s41433-019-0518-8. [Epub ahead of print] No abstract available.

PMID:
31289355
4.

An update on the modern management of paediatric uveitis.

Choi J, Hawley DP, Ashworth J, Edelsten C, Bossuyt ASAM.

Br J Ophthalmol. 2019 Dec;103(12):1685-1689. doi: 10.1136/bjophthalmol-2019-314212. Epub 2019 Jul 4. Review.

PMID:
31272956
5.

Areas of agreement in the management of childhood non-infectious chronic anterior uveitis in the UK.

Solebo AL, Rahi JS, Dick AD, Ramanan AV, Ashworth J, Edelsten C; Members of the POIG Uveitis Delphi Group.

Br J Ophthalmol. 2020 Jan;104(1):11-16. doi: 10.1136/bjophthalmol-2018-313789. Epub 2019 May 2.

PMID:
31048286
6.

Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.

Ramanan AV, Dick AD, Jones AP, Hughes DA, McKay A, Rosala-Hallas A, Williamson PR, Hardwick B, Hickey H, Rainford N, Hickey G, Kolamunnage-Dona R, Culeddu G, Plumpton C, Wood E, Compeyrot-Lacassagne S, Woo P, Edelsten C, Beresford MW.

Health Technol Assess. 2019 Apr;23(15):1-140. doi: 10.3310/hta23150.

7.

Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative.

Constantin T, Foeldvari I, Anton J, de Boer J, Czitrom-Guillaume S, Edelsten C, Gepstein R, Heiligenhaus A, Pilkington CA, Simonini G, Uziel Y, Vastert SJ, Wulffraat NM, Haasnoot AM, Walscheid K, Pálinkás A, Pattani R, Györgyi Z, Kozma R, Boom V, Ponyi A, Ravelli A, Ramanan AV.

Ann Rheum Dis. 2018 Aug;77(8):1107-1117. doi: 10.1136/annrheumdis-2018-213131. Epub 2018 Mar 28.

8.

Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis.

Ramanan AV, Dick AD, Jones AP, McKay A, Williamson PR, Compeyrot-Lacassagne S, Hardwick B, Hickey H, Hughes D, Woo P, Benton D, Edelsten C, Beresford MW; SYCAMORE Study Group.

N Engl J Med. 2017 Apr 27;376(17):1637-1646. doi: 10.1056/NEJMoa1614160.

9.

Dance therapy combined with patient education improves quality of life of persons with obesity: A pilot feasibility study for a randomised controlled trial.

Allet L, Müller-Pinget S, Punt I, Edelsten C, Ballif A, Golay A, Pataky Z.

Obes Res Clin Pract. 2017 Jan - Feb;11(1):79-87. doi: 10.1016/j.orcp.2016.03.005. Epub 2016 Apr 3.

PMID:
27053574
10.

Group A streptococcal endophthalmitis complicating a sore throat in a 2-year-old child.

Fitzgerald F, Harris K, Henderson R, Edelsten C.

BMJ Case Rep. 2015 Apr 9;2015. pii: bcr2014208168. doi: 10.1136/bcr-2014-208168.

11.

Possession of the HLA-DRB1*1501 allele and visual outcome in idiopathic intermediate uveitis.

Petrushkin H, Thomas D, Vaughan R, Kondeatis E, Stanford MR, Edelsten C, Wallace GR.

JAMA Ophthalmol. 2015 Apr;133(4):482-3. doi: 10.1001/jamaophthalmol.2014.5868. No abstract available.

PMID:
25634309
12.

Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients.

Hiwarkar P, Gajdosova E, Qasim W, Worth A, Breuer J, Chiesa R, Ridout D, Edelsten C, Moore A, Amrolia P, Veys P, Rao K.

Clin Infect Dis. 2014 Jun;58(12):1700-6. doi: 10.1093/cid/ciu201. Epub 2014 Apr 3.

PMID:
24700657
13.

A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial).

Ramanan AV, Dick AD, Benton D, Compeyrot-Lacassagne S, Dawoud D, Hardwick B, Hickey H, Hughes D, Jones A, Woo P, Edelsten C, Beresford MW; SYCAMORE Trial Management Group.

Trials. 2014 Jan 9;15:14. doi: 10.1186/1745-6215-15-14.

14.

Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience.

Russo RA, Melo-Gomes S, Lachmann HJ, Wynne K, Rajput K, Eleftheriou D, Edelsten C, Hawkins PN, Brogan PA.

Rheumatology (Oxford). 2014 Apr;53(4):665-70. doi: 10.1093/rheumatology/ket415. Epub 2013 Dec 17.

PMID:
24352339
15.

Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors.

Heiligenhaus A, Heinz C, Edelsten C, Kotaniemi K, Minden K.

Ocul Immunol Inflamm. 2013 Jun;21(3):180-91. doi: 10.3109/09273948.2013.791701. Review.

PMID:
23713827
16.

Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood.

Heiligenhaus A, Foeldvari I, Edelsten C, Smith JR, Saurenmann RK, Bodaghi B, de Boer J, Graham E, Anton J, Kotaniemi K, Mackensen F, Minden K, Nielsen S, Rabinovich EC, Ramanan AV, Strand V; Multinational Interdisciplinary Working Group for Uveitis in Childhood.

Arthritis Care Res (Hoboken). 2012 Sep;64(9):1365-72. doi: 10.1002/acr.21674. Review.

17.

Inflammatory lesions of the orbit: a single paediatric rheumatology centre experience.

Boulter EL, Eleftheriou D, Sebire NJ, Edelsten C, Brogan PA.

Rheumatology (Oxford). 2012 Jun;51(6):1070-5. doi: 10.1093/rheumatology/ker432. Epub 2012 Jan 31.

PMID:
22298792
18.

Tubulointerstitial nephritis, uveitis, hearing loss and vestibular failure: TINU-atypical Cogan's overlap syndrome.

Brogan K, Eleftheriou D, Rajput K, Edelsten C, Sebire NJ, Brogan PA.

Rheumatology (Oxford). 2012 May;51(5):950-2. doi: 10.1093/rheumatology/ker443. Epub 2012 Jan 11. No abstract available.

PMID:
22240503
19.

Reconsidering treatment options in childhood uveitis.

Edelsten C.

Br J Ophthalmol. 2007 Feb;91(2):133-4. No abstract available.

20.

Risks of relapse in patients with acute anterior uveitis.

Natkunarajah M, Kaptoge S, Edelsten C.

Br J Ophthalmol. 2007 Mar;91(3):330-4. Epub 2006 Oct 11.

21.

Are cytokine gene polymorphisms associated with outcome in patients with idiopathic intermediate uveitis in the United Kingdom?

Stanford MR, Vaughan RW, Kondeatis E, Chen Y, Edelsten CE, Graham EM, Wallace GR.

Br J Ophthalmol. 2005 Aug;89(8):1013-6.

22.

Orbital varices diagnosed as episcleritis in a child with juvenile idiopathic arthritis.

Misra A, Edelsten C.

J Pediatr. 2005 Apr;146(4):574. No abstract available.

PMID:
15812470
23.

The risk of complications of uveitis in a district hospital cohort.

Maini R, O'Sullivan J, Reddy A, Watson S, Edelsten C.

Br J Ophthalmol. 2004 Apr;88(4):512-7.

24.

Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program.

Chia A, Lee V, Graham EM, Edelsten C.

Am J Ophthalmol. 2003 Jun;135(6):757-62.

PMID:
12788113
25.

Visual loss associated with pediatric uveitis in english primary and referral centers.

Edelsten C, Reddy MA, Stanford MR, Graham EM.

Am J Ophthalmol. 2003 May;135(5):676-80.

PMID:
12719076
26.

Epstein-Barr virus dacryoadenitis as a complication of bone marrow transplant in a child with combined immunodeficiency.

Thomson J, Vassiliou G, Veys P, Redmill B, Edelsten C.

Eye (Lond). 2001 Dec;15(Pt 6):815-6. No abstract available.

PMID:
11827022
28.

Blindness following a diabetic foot infection: a variant to the 'eye-foot syndrome'?

Yuen KC, Baker NR, Reddy A, Edelsten C, Rayman G.

Diabet Med. 2000 Jul;17(7):546-9.

PMID:
10972587
29.

Branch retinal artery occlusion: a case complicating acute rheumatic fever and dental abscess.

Tillett A, Edelsten C.

Hosp Med. 2000 May;61(5):360-1. No abstract available.

PMID:
10953747
30.

The ocular and systemic prognosis of patients presenting with sarcoid uveitis.

Edelsten C, Pearson A, Joynes E, Stanford MR, Graham EM.

Eye (Lond). 1999 Dec;13 ( Pt 6):748-53.

PMID:
10707138
31.

Uveitis associated with parvovirus infection.

Maini R, Edelsten C.

Br J Ophthalmol. 1999 Dec;83(12):1403-4. No abstract available.

32.

Antiendothelial cell antibodies (AECA) in patients with uveoretinitis.

Edelsten C, D'Cruz DP.

Clin Rev Allergy Immunol. 1997 Spring;15(1):41-52. Review.

PMID:
9209800
33.

The British Ophthalmological Surveillance Unit: the study of uncommon ophthalmic disorders made easier.

Rahi JS, Edelsten C.

Eye (Lond). 1997;11 ( Pt 6):766-7. No abstract available.

PMID:
9537127
34.

Antibodies against retinal S-antigen in patients with juvenile chronic arthritis-associated uveitis.

Edelsten C, Zaman A, Leak AM, Muller S, Graham EM, Woo P.

Br J Rheumatol. 1996 Jan;35(1):101-2. No abstract available.

PMID:
8624615
35.

Systemic morbidity in patients with isolated idiopathic retinal vasculitis.

Palmer HE, Zaman AG, Edelsten CE, Stanford MR, Graham EM.

Lancet. 1995 Aug 19;346(8973):505-6. No abstract available.

PMID:
7637499
36.

Paraneoplastic retinopathy in association with large cell neuroendocrine bronchial carcinoma.

Stanford MR, Edelsten CE, Hughes JD, Sanders MD, Brooks CI, Mitchell D, Sheppard MN.

Br J Ophthalmol. 1995 Jun;79(6):617-8. No abstract available.

37.

Acute angle closure glaucoma: relative failure of YAG iridotomy in affected eyes and factors influencing outcome.

Buckley SA, Reeves B, Burdon M, Moorman C, Wheatcroft S, Edelsten C, Benjamin L.

Br J Ophthalmol. 1994 Jul;78(7):529-33.

38.

The efficacy of systemic corticosteroids in sight-threatening retinal vasculitis.

Howe LJ, Stanford MR, Edelsten C, Graham EM.

Eye (Lond). 1994;8 ( Pt 4):443-7.

PMID:
7821470
39.

Serpiginous choroiditis: an unusual presentation of ocular sarcoidosis.

Edelsten C, Stanford MR, Graham EM.

Br J Ophthalmol. 1994 Jan;78(1):70-1. No abstract available.

40.

Soluble intercellular adhesion molecule-1 (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitis.

Zaman AG, Edelsten C, Stanford MR, Graham EM, Ellis BA, Direskeneli H, D'Cruz DP, Hughes GR, Dumonde DC, Wallace GR.

Clin Exp Immunol. 1994 Jan;95(1):60-5.

41.
42.

Intermediate uveitis and sarcoidosis.

Graham EM, Edelsten C.

Dev Ophthalmol. 1992;23:106-10. No abstract available.

PMID:
1730340
43.

Anti-endothelial cell antibodies in retinal vasculitis.

Edelsten C, D'Cruz D, Hughes GR, Graham EM.

Curr Eye Res. 1992;11 Suppl:203-8.

PMID:
1424746

Supplemental Content

Loading ...
Support Center